ED50 of Intranasal Dexmedetomidine Sedation for Transthoracic Echocardiography in Children with or without a History of Cardiac Surgery for Cyanotic Congenital Heart Disease
Background and Objective. Dexmedetomidine (DEX) can provide adequate sedation during short procedures. However, the median effective dose (ED50) of intranasal DEX sedation has not been well established in children with a history of correction surgery for cyanotic congenital heart disease (cCHD). Thi...
Main Authors: | HongBin Gu, YunAn Song, Jie Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/1349432 |
Similar Items
-
Comparative study of intranasal dexmedetomidine v/s midazolam for sedation of pediatric patients during transthoracic echocardiography
by: Suvendu Panda, et al.
Published: (2021-01-01) -
Dexmedetomidine in a patient with unrepaired congenital cyanotic heart disease
by: Kumar Parag, et al.
Published: (2020-01-01) -
Intranasal dexmedetomidine is an effective sedative agent for electroencephalography in children
by: Hang Chen, et al.
Published: (2020-03-01) -
An Evaluation of Intranasal Sufentanil and Dexmedetomidine for Pediatric Dental Sedation
by: James M. Hitt, et al.
Published: (2014-03-01) -
Intranasal dexmedetomidine for paediatric sedation for diagnostic magnetic resonance imaging studies
by: Uday S Ambi, et al.
Published: (2012-01-01)